CKNTF — Cell Kinetics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Cell Kinetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 0.021 |
| Cost of Revenue | ||||
| Gross Profit | — | 0 | 0 | 0.007 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 1.75 | 1.78 | 2.08 | 2.42 |
| Operating Profit | -1.75 | -1.78 | -2.08 | -2.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -1.77 | -1.81 | -2.1 | -2.38 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1.77 | -1.81 | -2.1 | -2.38 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -1.77 | -1.81 | -2.1 | -2.38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -1.77 | -1.81 | -2.1 | -2.38 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.106 | -0.108 | -0.125 | -0.118 |
| Dividends per Share |